EDGAR Filing Documents for 0001485003-17-000008

Form 8-K - Current report:

SEC Accession No. 0001485003-17-000008

Filing Date

2017-03-06

Accepted

2017-03-06 17:00:54

Documents

Period of Report

2017-03-05

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	ebio-form8xkmccabeamendmen.htm	8-K	17759
2	EXHIBIT 10.1	mccabeamendment.htm	EX-10.1	5820
	Complete submission text file	0001485003-17-000008.txt		24814

Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142

Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911

Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)